Get Live Data

PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Scancell Holdings Share Price
  4. Scancell Holdings Share Regulatory News
  5. Annual Financial Report

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Scancell Holdings Information

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.10
Bid: 9.70
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 0.80 (8.247%)
Open: 10.10
High: 10.10
Low: 10.10
Prev. Close: 10.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

10 Jul 2013 10:55

RNS Number : 0084J
Scancell Holdings Plc
10 July 2013
 



Scancell Holdings plc

("Scancell" or the "Company")

 

Annual Report and Accounts

 

The Company announces that its annual report and accounts for the financial year ended 30 April 2013 have been posted to shareholders of the Company and a copy is available on the Company's website: www.scancell.co.uk

For Further Information:

 

Dr Richard Goodfellow, Joint CEO

Professor Lindy Durrant, Joint CEO

Scancell Holdings Plc

Scancell Holdings Plc

+ 44 (0) 74 2323 0497 

+ 44 (0) 74 2323 0497 

 

Simon Conway/Mo Noonan

FTI Consulting

+44 (0) 20 7831 3113

Camilla Hume/Stephen Keys

Cenkos Securities plc

+ 44 (0) 20 7397 8900

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSGCGDRSUBBGXG
123456789
Date   Source Headline
8th Oct 201210:43 amRNSHolding(s) in Company
8th Oct 201210:43 amRNSHolding(s) in Company
8th Oct 201210:31 amRNSNotice of Results and Share Price Movement
3rd Oct 20123:30 pmRNSChange of Advisers
10th Sep 201211:10 amRNSHolding(s) in Company
3rd Sep 20125:39 pmRNSHolding(s) in Company
23rd Aug 20127:00 amRNSHolding(s) in Company
20th Aug 20124:03 pmRNSHolding(s) in Company
20th Aug 20124:01 pmRNSMarket Update
17th Aug 20129:24 amRNSHolding(s) in Company
15th Aug 20121:12 pmRNSModitope Vaccine Technology Platform
19th Jun 20127:00 amRNSLong Term Treatment Approval
25th May 20127:00 amRNSVesting of Ichor Options
2nd May 20127:00 amRNSSCIB1 Update
17th Apr 20127:00 amRNSSCIB1 Trial Update
16th Apr 201211:34 amRNSHolding(s) in Company
13th Mar 20128:23 amRNSNotice of Investor Meeting
9th Mar 20127:00 amRNSPatent Approval
29th Feb 20123:49 pmRNSChange of Registered Office
31st Jan 20127:00 amRNSHalf Year Results
13th Dec 20114:28 pmPRNIssue of Equity
17th Nov 201111:29 amPRNHoldings in Company
4th Nov 20117:00 amPRNConfirmation of GBP2.85 million payment
25th Oct 20117:00 amPRNProgress on possible GBP2.85m payment
19th Aug 201112:25 pmPRNHolding(s) in Company
18th Aug 201111:37 amPRNAppointment of Director
17th Aug 20117:00 amPRNSCIB1: Safety Review and Dose Escalation
26th Jul 20111:01 pmPRNHolding(s) in Company
25th Jul 201112:45 pmPRNAGM & EGM Statement
30th Jun 201111:48 amPRNChange of Board Structure
30th Jun 201111:46 amPRNDevelopment of new vaccine for treating lung cancer
30th Jun 201111:44 amPRNPlacing to raise £1.73 million
30th Jun 201111:37 amPRNFinal Results
3rd Jun 20117:00 amPRNAppointment of Broker
31st Jan 20118:30 amPRNInterim Results
31st Jan 20117:00 amPRNSCIB1: Safety Review and Dose Escalation
28th Jan 20117:00 amPRNRe: SCIB1 Clinical Trial Patient Recruitment
13th Jan 20117:00 amPRNIssue of Equity
14th Dec 20102:25 pmPRNResult of AGM
14th Dec 20107:00 amPRNAGM Statement
7th Sep 201011:00 amPRNRe: ImmuneRegen Strategic Collaboration
6th Sep 20107:00 amPRNAppointment of Broker
10th Aug 20107:00 amPRNLicence Agreement with Cancer Research Technology
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.